Search
Subscribe Now
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Pharmaceutical Industry
Pharmaceutical Industry
C-Suite
How Pfizer’s CEO wielded moral clarity to help his team do the impossible
By
Ruth Umoh
February 2, 2026
Success
Pfizer CEO Albert Bourla’s best leadership advice: Being optimistic is better than being right
By
Preston Fore
January 31, 2026
C-Suite
‘We’ll save the world from cancer’: Inside Pfizer CEO’s $23 billion post‑COVID bet on oncology
By
Nick Lichtenberg
January 30, 2026
Health
As billionaires chase immortality, this startup cofounded by a Harvard genetics professor gets FDA approval for the first partial de-aging human trial
By
Marco Quiroz-Gutierrez
January 30, 2026
Workplace Culture
Walmart doubles down on health, promoting 3,000 pharmacy workers and upping earning potential—with no college degree required
By
Sydney Lake
January 29, 2026
C-Suite
Pfizer CEO on how he struck a deal with President Trump in 10 days to lower American drug costs
By
Fortune Editors
January 27, 2026
Investing
Inside Big Pharma and VC’s big bet on AI: You wouldn’t ‘want to fly an airplane designed by hand, but all of our drugs are designed like that’
By
Nick Lichtenberg
January 23, 2026
AI
AI drug startup Insilico Medicine launches an AI ‘gym’ to help models like GPT and Qwen be good at science
By
Nicholas Gordon
January 22, 2026
Economy
Trump says Europe does one thing right: drug prices. ‘A pill that costs $10 in London costs $130 in New York or Los Angeles’
By
Sasha Rogelberg
January 21, 2026
AI
Anthropic unveils Claude for Healthcare, expands life science features, and partners with HealthEx to let users connect medical records
By
Jeremy Kahn
January 11, 2026
Economy
Mark Cuban on the $38 trillion national debt and the absurdity of U.S. healthcare: we wouldn’t pay for potato chips like this
By
Nick Lichtenberg
January 6, 2026
Health
GLP-1s could end up being ‘the first true longevity drug’ as the world battles a rising obesity crisis
By
Angelica Ang
November 21, 2025
Newsletters
Why big pharma is teaming up with AI giants to speed up drug discovery and make work easier for health care workers
By
John Kell
November 19, 2025
Economy
Novo Nordisk CFO outlines ‘ultimate defense’ against stock downgrades and lawsuits to retain weight-loss crown
By
Eleanor Pringle
November 6, 2025
Workplace Culture
How pharma giant AbbVie holds leaders accountable for culture
By
Ted Kitterman
and
Great Place To Work
October 9, 2025
Most Popular
Success
In 2026, many employers are ditching merit-based pay bumps in favor of ‘peanut butter raises’
By
Emma Burleigh
Future of Work
Ford CEO has 5,000 open mechanic jobs with up to 6-figure salaries from the shortage of manually skilled workers: 'We...
By
Marco Quiroz-Gutierrez
Economy
'I just don't have a good feeling about this': Top economist Claudia Sahm says the economy quietly shifted and...
By
Eleanor Pringle